Area of research
Surgery · Oncology
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Urinary and Genital Oncology Studies, and Head and Neck Cancer Studies.
[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
DLL3 Expression in Neuroendocrine Carcinomas and Neuroendocrine Tumours: Insights From a Multicentric Cohort of 1294 Pulmonary and Extrapulmonary Neuroendocrine Neoplasms
Incidental Prompt Injections on Vision–Language Models in Real-Life Histopathology
Deep Learning Discovers New Morphological Features while Predicting Genetic Alterations from Histopathology of Papillary Thyroid Carcinoma
Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer
Treatment of Advanced or Metastatic Urothelial Cancer
Spatial Transcriptomics Expression Prediction from Histopathology Based on Cross-Modal Mask Reconstruction and Contrastive Learning
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy
Spatial transcriptomics expression prediction from histopathology based on cross-modal mask reconstruction and contrastive learning
Bispecific T cell engager therapy for refractory rheumatoid arthritis
<i>NECTIN4</i> Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer
Domain generalization across tumor types, laboratories, and species — Insights from the 2022 edition of the Mitosis Domain Generalization Challenge
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma
AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer
PITX2 as a Sensitive and Specific Marker of Midgut Neuroendocrine Tumors: Results from a Cohort of 1157 Primary Neuroendocrine Neoplasms
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy
A novel grading approach predicts worse outcomes in stage <scp>pT1</scp> non‐muscle‐invasive bladder cancer
Improving detection of carcinoma <i>in situ</i> in bladder cancer: urinary cytology vs the Xpert® <scp>BC</scp> Monitor
Towards interactive AI-authoring with prototypical few-shot classifiers in histopathology
An Empirical Survey on the Adaption of Neoadjuvant Chemotherapy in Bladder Cancer
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes
Contrast‐Enhanced Multispectral Optoacoustic Tomography for Functional Assessment of the Gastrointestinal Tract
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution
<scp>CD24</scp> targeting with <scp>NK‐CAR</scp> immunotherapy in testis, prostate, renal and (luminal‐type) bladder cancer and identification of direct <scp>CD24</scp> interaction partners
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial
Re: First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
<i>PD-L1</i> ( <i>CD274</i> ) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma